IndexProduct Concentration Risk [Member]
| Name | ProductConcentrationRiskMember |
|---|---|
| Namespace | http://fasb.org/us-gaap/2020-01-31 |
| Prefix | us-gaap |
| Data type | nonnum:domainItemType |
| Period type | duration |
| Substitution Group | xbrli:item |
| Balance | None |
| Nillable | True |
| Abstract | True |
Labels
| Text | Lang | Role | Container role |
|---|---|---|---|
| Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence. | en-US | http://www.xbrl.org/2003/role/documentation | http://www.xbrl.org/2003/role/link |
| Product Concentration Risk [Member] | en-US | http://www.xbrl.org/2003/role/label | http://www.xbrl.org/2003/role/link |
References
| Name | Value | Role |
|---|---|---|
| Publisher | FASB | http://fasb.org/us-gaap/role/ref/legacyRef |
| Name | Accounting Standards Codification | http://fasb.org/us-gaap/role/ref/legacyRef |
| Topic | 275 | http://fasb.org/us-gaap/role/ref/legacyRef |
| SubTopic | 10 | http://fasb.org/us-gaap/role/ref/legacyRef |
| Section | 50 | http://fasb.org/us-gaap/role/ref/legacyRef |
| Paragraph | 18 | http://fasb.org/us-gaap/role/ref/legacyRef |
| Subparagraph | (b) | http://fasb.org/us-gaap/role/ref/legacyRef |
| URI | http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 | http://fasb.org/us-gaap/role/ref/legacyRef |